:: ::
برگشت به فهرست مقالات برگشت به فهرست نسخه ها
Evaluation the effect of Atorvastatin 1% mouthwash in prevention of radiotherapy induced mucositis: a pilot study
چکیده:   (708 مشاهده)
Background: Oral mucositis is a troublesome symptom for people who receive radiotherapy and chemotherapy and it is a dose-dependent factor. Atorvastatin is a HMG-CoA reductase inhibitors and various studies have proved its anti-inflammatory effects. The goal of this study is to evaluate atorvastatin 1% mouthwash effects in prevention of radiotherapy induced mucositis.
Methods: Atorvastatin 1% suspension was prepared for mouthwash in this randomized, double blind clinical trial. Thirty patients were randomly received atorvastatin or placebo mouthwash. They had to gargle 5cc of mouthwash, 3 times per day during radiotherapy. The severity and pain of mucositis was evaluated every week, during their treatment.
Results: The severity of mucositis between the two study groups was significant every four weeks (p < 0.05) and the percentage of patients with more severe mucositis was less in the atorvastatin group. It is found that the pain intensity was lower after 3 and 4 weeks, in atorvastatin group.
Conclusion: These findings indicated that atorvastatin mouthwash showed a significant activity in relieving of radiotherapy induced oral mucositis and pain.
     
نوع مطالعه: Short Communication | موضوع مقاله: Oncology
دریافت: 1399/12/23 | پذیرش: 1400/6/27


XML   English Abstract   Print



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
برگشت به فهرست مقالات برگشت به فهرست نسخه ها